Fig. 2From: Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteinsDistribution and median values of the oxidation rate of DHR (ORD) of ultracentrifuged HDL fractions (UCHDL) from apparently healthy subjects (Controls) and patients with the cardiovascular disease (CVD patients), and of apoB-deleted (apoBd) plasma from Controls, CVD patients, and patients with high serum amyloid A protein levels (High SAA patients). Differences between groups were tested by Mann-Whitney U testBack to article page